Geron (GERN) Other Non-Current Liabilities (2012 - 2026)
Geron's (GERN) quarterly Other Non-Current Liabilities came in at $108.9 million in Q2 2026, down 1.44% year-over-year from $110.5 million in Q2 2025, and down 1.31% quarter-over-quarter from $110.4 million in Q1 2026.
Analysis
Geron (GERN) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Geron has disclosed Other Non-Current Liabilities across 6 years of filings, most recently posting $108.9 million for Q2 2026.
- In Q2 2026, Other Non-Current Liabilities fell 1.44% year-over-year to $108.9 million; the TTM figure through Jun 2026 stood at $108.9 million (down 1.44% YoY), while the FY2025 annual figure was $112.1 million, up 7.39% from the prior year.
- Other Non-Current Liabilities came in at $108.9 million for Q2 2026 at Geron, down from $110.4 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $112.1 million in Q4 2025 to a low of $104.4 million in Q4 2024.
- Average Other Non-Current Liabilities over 3 years is $109.5 million, with a median of $110.4 million recorded in 2025.
- Year-over-year, Other Non-Current Liabilities advanced 7.39% in 2025 and dropped 1.44% in 2026.
- Over 3 years, Other Non-Current Liabilities stood at $104.4 million in 2024, then grew by 7.39% to $112.1 million in 2025, then declined by 2.85% to $108.9 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $108.9 million in Q2 2026, $110.4 million in Q1 2026, and $112.1 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.93 Mn |
| Mar 31, 2026 | 110.38 Mn |
| Dec 31, 2025 | 112.13 Mn |
| Sep 30, 2025 | 110.04 Mn |
| Jun 30, 2025 | 110.53 Mn |
| Mar 31, 2025 | 110.38 Mn |
| Dec 31, 2024 | 104.42 Mn |
| Dec 31, 2014 | 16,000.00 |
| Sep 30, 2014 | 1,000.00 |
| Jun 30, 2014 | 290,000.00 |
| Mar 31, 2014 | 143,000.00 |
| Dec 31, 2013 | 367,000.00 |
| Sep 30, 2013 | 258,000.00 |
| Jun 30, 2013 | 50,000.00 |
| Mar 31, 2013 | 26,000.00 |
| Dec 31, 2012 | 51,000.00 |